Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 2/2013

01.02.2013 | Original Article

Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma

verfasst von: Giuseppe Malleo, Alfredo Tonsi, Giovanni Marchegiani, Andrea Casarotto, Salvatore Paiella, Giovanni Butturini, Roberto Salvia, Claudio Bassi

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aims of this paper were to evaluate the clinical features of patients with primary duodenal adenocarcinoma and to address the prognostic relevance of different surgical and pathological variables after potentially curative pancreaticoduodenectomy.

Methods

Patients with primary duodenal adenocarcinoma observed from 2000 through 2009 were identified from a single-institution electronic database. Univariate and multivariate analyses were performed to identify factors associated with survival.

Results

The study population consisted of 37 patients. Of these, 25 underwent pancreaticoduodenectomy, while the remaining 12 were not amenable to resection and underwent bypass operations or were given best supportive care. Overall survival after radical resection (R0) was significantly longer than after palliative surgery (180 versus 35 months, p = 0.013). On multivariate analysis, tumor grade (hazard ratio (HR) = 1.345, 95% CI = 1.28–1.91, p = 0.03) and the occurrence of postoperative or abdominal complications (HR = 1.781, 95% CI = 1.10–2.89, p = 0.037; HR = 1.878, 95% CI = 1.21–3.08, p = 0.029) were found to be significant prognostic factors for survival in patients undergoing potentially curative resection. In particular, median survival was 180 months in patients with an uneventful postoperative course and 52 months in those with abdominal complications. The 5-year overall survival rates were 100 and 60 %, respectively.

Conclusions

According to the present findings, the development of postoperative complications may be an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma. This emphasizes the need for centralization to high-volume centers where an appropriate postoperative care can be delivered.
Literatur
1.
Zurück zum Zitat Spira IA, Ghazi A, Wolff WI (1977) Primary adenocarcinoma of the duodenum. Cancer 39:1721–1726PubMedCrossRef Spira IA, Ghazi A, Wolff WI (1977) Primary adenocarcinoma of the duodenum. Cancer 39:1721–1726PubMedCrossRef
2.
3.
Zurück zum Zitat van Ooijen B, Kalsbeek HL (1988) Carcinoma of the duodenum. Surg Gynecol Obstet 166:343–347PubMed van Ooijen B, Kalsbeek HL (1988) Carcinoma of the duodenum. Surg Gynecol Obstet 166:343–347PubMed
4.
Zurück zum Zitat Joesting DR, Beart RW, van Heerden JA, Weiland LH (1981) Improving survival in adenocarcinoma of the duodenum. Am J Surg 141:228–231PubMedCrossRef Joesting DR, Beart RW, van Heerden JA, Weiland LH (1981) Improving survival in adenocarcinoma of the duodenum. Am J Surg 141:228–231PubMedCrossRef
5.
Zurück zum Zitat Rose DM, Hochwald SN, Klimstra DS, Brennan MF (1996) Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg 183:89–96PubMed Rose DM, Hochwald SN, Klimstra DS, Brennan MF (1996) Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg 183:89–96PubMed
6.
Zurück zum Zitat Barnes G Jr, Romero L, Hess KR, Curley SA (1994) Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol 1:73–78PubMedCrossRef Barnes G Jr, Romero L, Hess KR, Curley SA (1994) Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol 1:73–78PubMedCrossRef
7.
Zurück zum Zitat Santoro E, Sacchi M, Scutari F, Carboni F, Graziano F (1997) Primary adenocarcinoma of the duodenum: treatment and survival in 89 patients. Hepatogastroenterology 44:1157–1163PubMed Santoro E, Sacchi M, Scutari F, Carboni F, Graziano F (1997) Primary adenocarcinoma of the duodenum: treatment and survival in 89 patients. Hepatogastroenterology 44:1157–1163PubMed
8.
Zurück zum Zitat Sohn TA, Lillemoe KD, Cameron JL, Pitt HA, Kaufman HS, Hruban RH, Yeo CJ (1998) Adenocarcinoma of the duodenum: factors influencing long-term survival. J Gastrointest Surg 2:79–87PubMedCrossRef Sohn TA, Lillemoe KD, Cameron JL, Pitt HA, Kaufman HS, Hruban RH, Yeo CJ (1998) Adenocarcinoma of the duodenum: factors influencing long-term survival. J Gastrointest Surg 2:79–87PubMedCrossRef
9.
Zurück zum Zitat Bucher P, Gervaz P, Morel P (2005) Long-term results of radical resection for locally advanced duodenal adenocarcinoma. Hepatogastroenterology 52:1727–1729PubMed Bucher P, Gervaz P, Morel P (2005) Long-term results of radical resection for locally advanced duodenal adenocarcinoma. Hepatogastroenterology 52:1727–1729PubMed
10.
Zurück zum Zitat Cecchini S, Correa-Gallego C, Desphande V, Ligorio M, Dursun A, Wargo J, Fernàndez-Del Castillo C, Warshaw AL, Ferrone CR (2012) Superior prognostic importance of perineural invasion vs. lymph node involvement after curative resection of duodenal adenocarcinoma. J Gastrointest Surg 16:113–120PubMedCrossRef Cecchini S, Correa-Gallego C, Desphande V, Ligorio M, Dursun A, Wargo J, Fernàndez-Del Castillo C, Warshaw AL, Ferrone CR (2012) Superior prognostic importance of perineural invasion vs. lymph node involvement after curative resection of duodenal adenocarcinoma. J Gastrointest Surg 16:113–120PubMedCrossRef
11.
Zurück zum Zitat Zhang S, Cui Y, Zhong B, Xiao W, Gong X, Chao K, Chen M (2011) Clinicopathological characteristics and survival analysis of primary duodenal cancers: a 14-year experience in a tertiary centre in South China. Int J Colorectal Dis 26:219–226PubMedCrossRef Zhang S, Cui Y, Zhong B, Xiao W, Gong X, Chao K, Chen M (2011) Clinicopathological characteristics and survival analysis of primary duodenal cancers: a 14-year experience in a tertiary centre in South China. Int J Colorectal Dis 26:219–226PubMedCrossRef
12.
Zurück zum Zitat Chung WC, Paik CN, Jung SH, Lee KM, Kim SW, Chang UI, Yang JM (2011) Prognostic factors associated with survival in patients with primary duodenal adenocarcinoma. Korean J Intern Med 26:34–40PubMedCrossRef Chung WC, Paik CN, Jung SH, Lee KM, Kim SW, Chang UI, Yang JM (2011) Prognostic factors associated with survival in patients with primary duodenal adenocarcinoma. Korean J Intern Med 26:34–40PubMedCrossRef
13.
Zurück zum Zitat Howe JR, Klimstra DS, Moccia RD, Conlon KC, Brennan MF (1998) Factors predictive of survival in ampullary carcinoma. Ann Surg 228:87–94PubMedCrossRef Howe JR, Klimstra DS, Moccia RD, Conlon KC, Brennan MF (1998) Factors predictive of survival in ampullary carcinoma. Ann Surg 228:87–94PubMedCrossRef
14.
Zurück zum Zitat Conlon KC, Klimstra DS, Brennan MF (1996) Long-term survival after curative resection for pancreatic ductal adenocarcinoma: clinicopathological analysis of 5-year survivors. Ann Surg 223:273–279PubMedCrossRef Conlon KC, Klimstra DS, Brennan MF (1996) Long-term survival after curative resection for pancreatic ductal adenocarcinoma: clinicopathological analysis of 5-year survivors. Ann Surg 223:273–279PubMedCrossRef
15.
Zurück zum Zitat Brennan MF (1990) Duodenal cancer. Asian J Surgery 13:204–209 Brennan MF (1990) Duodenal cancer. Asian J Surgery 13:204–209
16.
Zurück zum Zitat Bakaeen FG, Murr MM, Sarr MG, Thompson GB, Farnell MB, Nagorney DM, Farley DR, van Heerden JA, Wiersema LM, Schleck CD, Donohue JH (2000) What prognostic factors are important in duodenal adenocarcinoma? Arch Surg 135:635–641PubMedCrossRef Bakaeen FG, Murr MM, Sarr MG, Thompson GB, Farnell MB, Nagorney DM, Farley DR, van Heerden JA, Wiersema LM, Schleck CD, Donohue JH (2000) What prognostic factors are important in duodenal adenocarcinoma? Arch Surg 135:635–641PubMedCrossRef
17.
Zurück zum Zitat Sarela AI, Brennan MF, Karpeh MS, Klimstra D, Conlon KC (2004) Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer. Ann Surg Oncol 11:380–386PubMedCrossRef Sarela AI, Brennan MF, Karpeh MS, Klimstra D, Conlon KC (2004) Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer. Ann Surg Oncol 11:380–386PubMedCrossRef
18.
Zurück zum Zitat Tocchi A, Mazzoni G, Puma F, Miccini M, Cassini D, Bettelli E, Tagliacozzo S (2003) Adenocarcinoma of the third and fourth portions of the duodenum: results of surgical treatment. Arch Surg 138:80–85PubMedCrossRef Tocchi A, Mazzoni G, Puma F, Miccini M, Cassini D, Bettelli E, Tagliacozzo S (2003) Adenocarcinoma of the third and fourth portions of the duodenum: results of surgical treatment. Arch Surg 138:80–85PubMedCrossRef
19.
Zurück zum Zitat Poultsides GA, Huang LC, Cameron JL, Tuli R, Lan L, Hruban RH, Pawlik TM, Herman JM, Edil BH, Ahuja N, Choti MA, Wolfgang CL, Schulick RD (2012) Duodenal Adenocarcinoma: clinicopathologic analysis and implications for treatment. Ann Surg Oncol 19:1923–1935 Poultsides GA, Huang LC, Cameron JL, Tuli R, Lan L, Hruban RH, Pawlik TM, Herman JM, Edil BH, Ahuja N, Choti MA, Wolfgang CL, Schulick RD (2012) Duodenal Adenocarcinoma: clinicopathologic analysis and implications for treatment. Ann Surg Oncol 19:1923–1935
20.
Zurück zum Zitat Onkendi EO, Boostrom SY, Sarr MG, Farnell MB, Nagorney DM, Donohue JH, Kendrick ML, Reid-Lombardo KM, Harmsen WS, Que FG (2012) 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas. J Gastrointest Surg 16:682–691PubMedCrossRef Onkendi EO, Boostrom SY, Sarr MG, Farnell MB, Nagorney DM, Donohue JH, Kendrick ML, Reid-Lombardo KM, Harmsen WS, Que FG (2012) 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas. J Gastrointest Surg 16:682–691PubMedCrossRef
21.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2009) AJCC cancer staging manual, 7th edn. Springer, New York Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2009) AJCC cancer staging manual, 7th edn. Springer, New York
22.
Zurück zum Zitat Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M, International Study Group on Pancreatic Fistula Definition (2005) Postoperative pancreatic fistula: an International Study Group (ISGPF) definition. Surgery 138:8–13PubMedCrossRef Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M, International Study Group on Pancreatic Fistula Definition (2005) Postoperative pancreatic fistula: an International Study Group (ISGPF) definition. Surgery 138:8–13PubMedCrossRef
23.
Zurück zum Zitat Ryder NM, Ko CY, Hines OJ, Gloor B, Reber HA (2000) Primary duodenal adenocarcinoma: a 40-year experience. Arch Surg 135:1070–1074PubMedCrossRef Ryder NM, Ko CY, Hines OJ, Gloor B, Reber HA (2000) Primary duodenal adenocarcinoma: a 40-year experience. Arch Surg 135:1070–1074PubMedCrossRef
24.
Zurück zum Zitat Han SL, Cheng J, Zhou HZ, Zeng QQ, Lan SH (2010) The surgical treatment and outcome for primary duodenal adenocarcinoma. J Gastrointest Cancer 41:243–247PubMedCrossRef Han SL, Cheng J, Zhou HZ, Zeng QQ, Lan SH (2010) The surgical treatment and outcome for primary duodenal adenocarcinoma. J Gastrointest Cancer 41:243–247PubMedCrossRef
25.
Zurück zum Zitat Stell D, Mayer D, Mirza D, Buckels J (2004) Delayed diagnosis and lower resection rate of adenocarcinoma of the distal duodenum. Dig Surg 21:434–438PubMedCrossRef Stell D, Mayer D, Mirza D, Buckels J (2004) Delayed diagnosis and lower resection rate of adenocarcinoma of the distal duodenum. Dig Surg 21:434–438PubMedCrossRef
26.
Zurück zum Zitat Hung FC, Kuo CM, Chuah SK, Kuo CH, Chen YS, Lu SN, Chang Chien CS (2007) Clinical analysis of primary duodenal adenocarcinoma: an 11-year experience. J Gastroenterol Hepatol 22:724–728PubMedCrossRef Hung FC, Kuo CM, Chuah SK, Kuo CH, Chen YS, Lu SN, Chang Chien CS (2007) Clinical analysis of primary duodenal adenocarcinoma: an 11-year experience. J Gastroenterol Hepatol 22:724–728PubMedCrossRef
27.
Zurück zum Zitat Lee HG, You DD, Paik KY, Heo JS, Choi SH, Choi DW (2008) Prognostic factors for primary duodenal adenocarcinoma. World J Surg 32:2246–2252PubMedCrossRef Lee HG, You DD, Paik KY, Heo JS, Choi SH, Choi DW (2008) Prognostic factors for primary duodenal adenocarcinoma. World J Surg 32:2246–2252PubMedCrossRef
28.
Zurück zum Zitat Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA (1998) Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 227:821–831PubMedCrossRef Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA (1998) Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 227:821–831PubMedCrossRef
29.
Zurück zum Zitat Hirai T, Yamashita Y, Mukaida H, Kuwahara M, Inoue H, Toge T (1998) Poor prognosis in esophageal cancer patients with postoperative complications. Surg Today 28:576–579PubMedCrossRef Hirai T, Yamashita Y, Mukaida H, Kuwahara M, Inoue H, Toge T (1998) Poor prognosis in esophageal cancer patients with postoperative complications. Surg Today 28:576–579PubMedCrossRef
30.
Zurück zum Zitat Rizk NP, Bach PB, Schrag D, Bains MS, Turnbull AD, Karpeh M, Brennan MF, Rusch VW (2004) The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg 198:42–50PubMedCrossRef Rizk NP, Bach PB, Schrag D, Bains MS, Turnbull AD, Karpeh M, Brennan MF, Rusch VW (2004) The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg 198:42–50PubMedCrossRef
31.
Zurück zum Zitat McArdle CS, McMillan DC, Hole DJ (2005) Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer. Br J Surg 92:1150–1154PubMedCrossRef McArdle CS, McMillan DC, Hole DJ (2005) Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer. Br J Surg 92:1150–1154PubMedCrossRef
32.
Zurück zum Zitat Law WL, Choi HK, Lee YM, Ho JW (2007) The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer. Ann Surg Oncol 14:2559–2566PubMedCrossRef Law WL, Choi HK, Lee YM, Ho JW (2007) The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer. Ann Surg Oncol 14:2559–2566PubMedCrossRef
33.
Zurück zum Zitat Laurent C, Sa Cunha A, Couderc P, Rullier E, Saric J (2003) Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 90:1131–1136PubMedCrossRef Laurent C, Sa Cunha A, Couderc P, Rullier E, Saric J (2003) Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 90:1131–1136PubMedCrossRef
34.
Zurück zum Zitat Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539–545PubMedCrossRef Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539–545PubMedCrossRef
35.
Zurück zum Zitat Jamieson NB, Glen P, McMillan DC, McKay CJ, Foulis AK, Carter R, Imrie CW (2005) Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer 92:21–23PubMedCrossRef Jamieson NB, Glen P, McMillan DC, McKay CJ, Foulis AK, Carter R, Imrie CW (2005) Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer 92:21–23PubMedCrossRef
36.
Zurück zum Zitat Sharaiha RZ, Halazun KJ, Mirza F, Port JL, Lee PC, Neugut AI, Altorki NK, Abrams JA (2011) Elevated preoperative neutrophil: lymphocyte ratio as a predictor of postoperative disease recurrence in oesophageal cancer. Ann Surg Oncol 18:3362–3369PubMedCrossRef Sharaiha RZ, Halazun KJ, Mirza F, Port JL, Lee PC, Neugut AI, Altorki NK, Abrams JA (2011) Elevated preoperative neutrophil: lymphocyte ratio as a predictor of postoperative disease recurrence in oesophageal cancer. Ann Surg Oncol 18:3362–3369PubMedCrossRef
37.
Zurück zum Zitat Ding PR, An X, Zhang RX, Fang YJ, Li LR, Chen G, Wu XJ, Lu ZH, Lin JZ, Kong LH, Wan DS, Pan ZZ (2010) Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. Int J Colorectal Dis 25:1427–1433PubMedCrossRef Ding PR, An X, Zhang RX, Fang YJ, Li LR, Chen G, Wu XJ, Lu ZH, Lin JZ, Kong LH, Wan DS, Pan ZZ (2010) Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. Int J Colorectal Dis 25:1427–1433PubMedCrossRef
38.
Zurück zum Zitat Kneuertz PJ, Patel SH, Chu CK, Maithel SK, Sarmiento JM, Delman KA, Staley CA 3rd, Kooby DA (2011) Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma. Ann Surg Oncol 18:1327–1334PubMedCrossRef Kneuertz PJ, Patel SH, Chu CK, Maithel SK, Sarmiento JM, Delman KA, Staley CA 3rd, Kooby DA (2011) Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma. Ann Surg Oncol 18:1327–1334PubMedCrossRef
39.
Zurück zum Zitat Swartz MJ, Hughes MA, Frassica DA, Herman J, Yeo CJ, Riall TS, Lillemoe KD, Cameron JL, Donehower RC, Laheru DA, Hruban RH, Abrams RA (2007) Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. Arch Surg 142:285–288PubMedCrossRef Swartz MJ, Hughes MA, Frassica DA, Herman J, Yeo CJ, Riall TS, Lillemoe KD, Cameron JL, Donehower RC, Laheru DA, Hruban RH, Abrams RA (2007) Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. Arch Surg 142:285–288PubMedCrossRef
Metadaten
Titel
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma
verfasst von
Giuseppe Malleo
Alfredo Tonsi
Giovanni Marchegiani
Andrea Casarotto
Salvatore Paiella
Giovanni Butturini
Roberto Salvia
Claudio Bassi
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 2/2013
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-012-0978-9

Weitere Artikel der Ausgabe 2/2013

Langenbeck's Archives of Surgery 2/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.